Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers reach milestone in fight against lymphatic filariasis

05.12.2002


Four annual mass treatments of single doses of safe and inexpensive drugs found effective



Researchers report in the December 5 issue of the New England Journal of Medicine reaching an important milestone in learning how to halt a major mosquito-borne disease affecting 120 million people around the world. The disease, called lymphatic filariasis and commonly known as elephantiasis, is a leading cause of physical disfigurement, social ostracism, and economic loss throughout Africa, Asia, South America, and islands of the Pacific Ocean. The disease can lead to dramatically swollen and disfigured legs, arms, breasts, and genitals.

Treating 2500 residents in a remote area of Papua New Guinea in the South Pacific, the researchers from Case Western Reserve University School of Medicine, University Hospitals of Cleveland, and Papua New Guinea Institute of Medical Research found dramatic results with four annual mass treatments of single doses of safe and inexpensive anti-filarial (anti-worm) drugs. There was a greater than 95 percent decrease in mosquito transmission, nearly complete prevention of new infections in children, reduction of infection rates in the communities to less than one percent, and remarkably, cure of severe disease manifestations such as extremely enlarged arms and legs, and genital disfigurement. Combined with conclusions drawn from mathematical analysis of the interrelationships between the potentials of mosquito transmission and human infection, the report clearly sets the precedent that annual mass treatment with safe and inexpensive medications can go a long way toward eliminating this devastating disease.


James W. Kazura, M.D., the paper’s senior author, notes that this work represents an important milestone in the world-wide effort to combat filariasis. "Until this study, it was not clear that eradication and significant decreases in mosquito-borne transmission and disease severity could be realized even on a small scale." Kazura is a professor of medicine at CWRU and UHC.

Lymphatic filariasis is caused by microscopic juvenile parasitic worms that are transmitted to humans by mosquitoes containing these infective parasites. The juvenile parasites migrate from the site of the mosquito bite and ultimately develop into adult worms in the lymphatic system of the human host, where they cause the hallmark inflammation of filariasis. In many rural areas of Papua New Guinea, Africa, and India, nearly 10 percent of persons suffer from elephantiasis by adulthood, and large numbers of men develop such swelling of the scrotum that it can reach the size of a grapefruit. Transmission is continued in nature when the microscopic offspring of adult worms, called microfilariae, circulate in the bloodstream and are subsequently ingested by blood-feeding mosquitoes. After further development in the mosquito, the parasites are capable of infecting humans when the insect takes its next blood meal.

Building on more than 20 years of research and clinical investigations on filariasis, the project was conducted in Papua New Guinea, where transmission of filariasis and other serious infectious diseases such as malaria reach the highest levels seen anywhere in the world.

"Performance of a study in this setting to determine whether inexpensive and safe medications could decrease transmission of filariasis and control its clinical outcomes represents an extraordinarily tough test or ’proof of principle’ of the Global Plan to Eradicate Lymphatic Filariasis," says Kazura. "This plan, officially launched by the World Health Assembly in Geneva in 1997, states that filariasis is one of six diseases that is potentially eradicable. The target date to achieve this goal at a global level has been set at 2020. With support from the Bill and Melinda Gates Foundation and other non-governmental philanthropic organizations, administration by the Global Alliance through the Carter Center in Atlanta and World Health Organization, and donation of anti-filarial drugs by GlaxoSmithKline and Merck Pharmaceuticals, the infrastructure to implement the control plan in Africa, Latin America, Asia, and Pacific island nations has been growing over the past several years.

"This study provides essential guidelines to control this infectious disease and points the way to the ultimate eradication of filariasis on a global level," says Kazura.

"The work also poses interesting and challenging new research questions that should enable the testing of new hypotheses on how genetics and immunity determine infection susceptibility in humans and contribute to the development and ultimately prevention of lymphatic disease," he says.

An accompanying editorial written by Eric A. Ottesen, M.D., of Emory University, says this study has yielded important conclusions. "It should serve as a touchstone for future evaluations of other programs, both inside and outside the research community," it states.

George Stamatis | EurekAlert!
Further information:
http://www.cwru.edu/

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>